Monitor for operational milestones such as Jakarta clinic opening and membership enrollment numbers. The $1M investment is small relative to market cap, so near-term stock movement will likely depend on broader market sentiment toward the company's execution ability rather than this announcement alone.
Price Chart
Executive Summary
Instinct Bio announced plans to launch a subscription-model beauty clinic chain in Indonesia under its GENRÉVER CLINIC brand, with an initial $1M investment for five clinics. The filing is a forward-looking strategic announcement with no historical financial data, making the near-term impact highly uncertain for this $16M micro-cap.
Key Facts
- Initial investment of approximately US$1 million to establish five directly operated clinics in Jakarta, Surabaya, Bandung, Medan, and Bali.
- Subscription-based membership model with flat-fee, cancel-anytime structure, targeting Indonesia's medical aesthetics market estimated at ~$260M (2023) growing to ~$500M by 2029 (11.5% CAGR).
- Company has entered into an agreement with local physician Dr. Mario Damianus Daniel Hadinoto for medical oversight and regulatory compliance.
- Expansion is phase-gated and self-funded, with Jakarta clinic serving as initial validation platform.
Financial Impact
Initial investment of ~$1M; no revenue or profitability projections provided.
Risk Factors
- Execution risk: no assurance of successful clinic launch, profitability, or customer acceptance.
- Regulatory risk: subject to Indonesian healthcare licensing and foreign investment restrictions.
- Competition: established aesthetic clinics and prepaid package models dominate the market.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-088487 |
| Document: tm2621671d1_6k.htm | 0001104659-26-088487 |
| Document: 0001104659-26-088487-index-headers.html | 0001104659-26-088487 |
| Document: 0001104659-26-088487-index.html | 0001104659-26-088487 |
| Document: 0001104659-26-088487.txt | 0001104659-26-088487 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 6-K | $0.2300 | awaiting T+20 | — | $0.2007 (−12.74%) |
Oct 1, 2026 26d ago | 6-K | $0.3533 | awaiting T+20 | — | $0.2007 (−43.19%) |
Sep 15, 2026 6w ago | 6-K | $0.3700 $0.3602 | ▲ +2.65% | ▲ +5.63% | $0.2007 (+45.76%) |
Aug 10, 2026 11w ago | 6-K | $0.4019 $0.3863 | ▼ −3.88% | ▼ −2.97% | $0.2007 (−50.06%) |
Jul 30, 2026 12w ago | 6-K | $0.4990 $0.4470 | ▼ −10.42% | ▼ −14.39% | $0.2007 (−59.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers